Insider Transactions in Q2 2021 at Cme Group Inc. (CME)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 25
2021
|
Timothy S. Bitsberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+4.9%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Charles P Carey Director |
BUY
Grant, award, or other acquisition
|
Indirect |
917
+16.49%
|
$199,906
$218.12 P/Share
|
Jun 25
2021
|
Michael G. Dennis Global Head of Fixed Income |
BUY
Grant, award, or other acquisition
|
Direct |
551
+30.16%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Dennis Chookaszian Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+14.07%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Ana Dutra Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+7.89%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Martin J Gepsman Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+1.9%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Patrick W Maloney Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+30.31%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Robert J Tierney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+22.77%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Patrick J Mulchrone Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+1.08%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Elizabeth A Cook Director |
BUY
Grant, award, or other acquisition
|
Indirect |
551
+2.72%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
William W Hobert Director |
BUY
Grant, award, or other acquisition
|
Direct |
917
+1.11%
|
$199,906
$218.12 P/Share
|
Jun 25
2021
|
Daniel R Glickman Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+3.55%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Phyllis M Lockett Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+22.77%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Daniel G Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+22.77%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Dennis Suskind Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+15.03%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Deborah J Lucas Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+17.73%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
William R Shepard Director |
BUY
Grant, award, or other acquisition
|
Indirect |
917
+0.46%
|
$199,906
$218.12 P/Share
|
Jun 25
2021
|
Howard J Siegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
917
+1.12%
|
$199,906
$218.12 P/Share
|
Jun 25
2021
|
Rahael Seifu Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+30.37%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Terry L Savage Director |
BUY
Grant, award, or other acquisition
|
Indirect |
551
+2.91%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Larry G Gerdes Director |
BUY
Grant, award, or other acquisition
|
Direct |
917
+2.43%
|
$199,906
$218.12 P/Share
|
Jun 14
2021
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
SELL
Open market or private sale
|
Direct |
4,092
-8.79%
|
$879,780
$215.31 P/Share
|
Jun 14
2021
|
Howard J Siegel Director |
SELL
Open market or private sale
|
Direct |
1,500
-1.84%
|
$322,500
$215.0 P/Share
|
Jun 11
2021
|
Elizabeth A Cook Director |
SELL
Grant, award, or other acquisition
|
Indirect |
1,000
-2.51%
|
$214,000
$214.11 P/Share
|
Jun 09
2021
|
Elizabeth A Cook Director |
SELL
Open market or private sale
|
Indirect |
2,000
-4.55%
|
$432,000
$216.13 P/Share
|
May 27
2021
|
Julie Winkler Sr MD Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,500
-12.11%
|
$759,500
$217.0 P/Share
|
May 26
2021
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
SELL
Bona fide gift
|
Direct |
395
-0.84%
|
-
|
May 25
2021
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
SELL
Bona fide gift
|
Direct |
233
-0.49%
|
-
|
May 19
2021
|
Terrence A Duffy Chairman and CEO |
SELL
Open market or private sale
|
Direct |
29,000
-34.32%
|
$6,090,000
$210.83 P/Share
|
May 17
2021
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Bona fide gift
|
Indirect |
1,800
-10.17%
|
-
|
May 12
2021
|
Julie Holzrichter Sr MD Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,000
-14.12%
|
$1,278,000
$213.29 P/Share
|